Search the Newsreel

Gross margin % of Lithium Argentina AG Shs Cert Deposito Arg Repr 1 Sh – BCBA:LAAC.CI

The article displays the "Gross margin %" for Lithium Argentina AG Shs Cert Deposito Arg Repr 1 Sh, traded under the symbol BCBA:LAAC.CI on the Buenos Aires Stock Exchange. It indicates that the market is closed with no trades. The content primarily consists of …

ETFs Investing in Banco Bilbao Vizcaya Argentaria, S.A. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Banco Bilbao Vizcaya Argentaria, S.A. (BBVAE). The ETFs are sorted by market value and include details such as weight in the fund, issuer, management style, expense ratio, AUM, price, change, and 3-year …

Marathon Petroleum (MPC) Is Up 19.2% After Massive Q2 Profit Jump And Near-Complete Buyback - Has The Bull Case Changed?

(BBVA) Price Dynamics and Execution-Aware Positioning

Stock Traders Daily provides an AI-driven analysis of Banco Bilbao Vizcaya Argentaria S.a. (NASDAQ: BBVA), indicating strong sentiment across all time horizons. The analysis offers three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with support and resistance levels for various timeframes. The …

Regency Centers (REG) Q2 2026 Earnings Call Transcript

$2.2 billion uranium project begins construction in northern Saskatchewan

NexGen Energy Ltd has commenced construction on its $2.2 billion Rook I Project in northern Saskatchewan, marking the start of Canada's largest development-stage uranium project. The underground mine and mill will tap into the Arrow Deposit, one of the world's highest-grade uranium deposits, to …

Walleye Capital LLC Invests $2.44 Million in REGENXBIO Inc. $RGNX

Walleye Capital LLC has invested $2.44 million in REGENXBIO Inc. by acquiring 203,726 shares during the second quarter, making them one of many institutional investors in the company. REGENXBIO exceeded analyst expectations with its recent earnings report, posting $0.43 EPS and $108.02 million in …

Principal Financial Group Inc. Has $21.39 Million Stock Position in Portland General Electric Company $POR

7,506 Shares in Regeneron Pharmaceuticals, Inc. $REGN Acquired by Summit Global Investments

Summit Global Investments acquired 7,506 shares of Regeneron Pharmaceuticals (NASDAQ:REGN) valued at $4.68 million during the second quarter. Regeneron reported strong quarterly results, beating analyst estimates with $14.29 EPS and $4.29 billion in revenue, representing a 16.7% year-over-year increase. Despite a "Moderate Buy" consensus …

Oppenheimer Asset Management Inc. Takes $33.65 Million Position in Dollar General Corporation $DG

Oppenheimer Asset Management Inc. has acquired a new position of 292,319 shares in Dollar General Corporation, valued at approximately $33.65 million, representing a 0.13% stake in the company. Institutional investors and hedge funds collectively own 91.77% of Dollar General. Despite recent price target reductions …

General Mills (GIS) Seeks Bylaw Changes On Officer Liability

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. General Mills (NYSE: GIS) has put forward a proposal to amend its bylaws to address officer exculpation and a federal forum selection provision at its upcoming shareholder …

11 Best New Dollar Tree Fall Living Room Finds Under $1.50

This article highlights 11 affordable fall living room decor items available at Dollar Tree, all priced under $1.50. It suggests incorporating natural textures, warm metallics, and decorative accents for a modest seasonal refresh without breaking the bank. The list includes items like woven baskets, …

TCW Group Inc. Has $10.27 Million Stock Position in Amgen Inc. $AMGN

TCW Group Inc. increased its stake in Amgen Inc. by 12.8% in the second quarter, now holding 28,369 shares valued at $10.27 million. Institutional investors own 76.5% of Amgen's stock, while company insiders have recently sold shares worth over $2.5 million. Amgen reported strong …

Jennison Associates LLC Purchases 75,212 Shares of Amgen Inc. $AMGN

Jennison Associates LLC increased its stake in Amgen Inc. by 57.9% during the second quarter, acquiring an additional 75,212 shares and bringing its total holdings to 205,192 shares valued at $74.3 million. Other institutional investors also modified their positions in Amgen. The company recently …

Renaissance Technologies LLC Sells 257,900 Shares of Agenus Inc. $AGEN

Renaissance Technologies LLC has reduced its stake in Agenus Inc. (NASDAQ:AGEN) by 47.4% in the first quarter, selling 257,900 shares and now owning 285,646 shares valued at approximately $954,000. Institutional investors collectively hold 61.46% of Agenus. Despite mixed analyst ratings, the biotechnology company's shares …

California State Teachers Retirement System Grows Stock Holdings in Urogen Pharma $URGN

The California State Teachers Retirement System significantly increased its holdings in Urogen Pharma (NASDAQ:URGN) by 1,605.5% in the first quarter, now owning 38,750 shares valued at $697,000. Institutional investors collectively hold 91.29% of the company, which has an average analyst rating of "Moderate Buy" …

Vontobel Holding Ltd. Acquires 4,637 Shares of Amgen Inc. $AMGN

Vontobel Holding Ltd. increased its stake in Amgen Inc. by 3.1% during the second quarter, acquiring an additional 4,637 shares to hold a total of 155,115 shares valued at $56.17 million. Other hedge funds also adjusted their positions in Amgen, with several boosting their …

Walleye Capital LLC Invests $6.80 Million in Allogene Therapeutics, Inc. $ALLO

Walleye Capital LLC has invested $6.80 million in Allogene Therapeutics, acquiring 3.27 million shares, representing approximately 0.95% of the company. Other institutional investors have also adjusted their stakes, with a significant 83.63% of the stock owned by institutional investors and hedge funds. Allogene Therapeutics …

Massachusetts Financial Services Co. MA Raises Position in Portland General Electric Company $POR

Surience Private Wealth LLC Acquires Shares of 89,824 General Mills, Inc. $GIS

Surience Private Wealth LLC recently acquired 89,824 shares of General Mills (NYSE: GIS) valued at approximately $3.1 million, making it the 11th largest holding in their portfolio. Despite institutional investors owning 75.71% of the company, analyst sentiment leans cautious with a consensus "Reduce" rating …

BioNexus Gene Lab Corp (BGLC) CEO reports 338,709-share award and 11.5% stake

BioNexus Gene Lab Corp (BGLC) CEO Su-Leng Tan Lee was granted 338,709 shares as a fully vested Other Stock-Based Award under the company’s 2025 Equity Incentive Plan for completed services. This award gives her beneficial ownership of approximately 11.5% of the outstanding common stock, …

NewEdge Advisors LLC Trims Position in Biogen Inc. $BIIB

NewEdge Advisors LLC significantly reduced its stake in Biogen Inc. by 38.1% in the first quarter, selling 8,017 shares and retaining 13,031 shares valued at $2.39 million. Despite this, institutional investors still collectively own 87.93% of Biogen. The biotechnology company recently surpassed analyst expectations …

Elyxium Wealth LLC Has $5.16 Million Holdings in Amgen Inc. $AMGN

Elyxium Wealth LLC significantly increased its stake in Amgen Inc. (NASDAQ:AMGN) by 607.3% in the second quarter, bringing its total holdings to $5.16 million. This move is part of a broader trend of institutional investment in Amgen, which recently reported strong quarterly earnings, raising …

Genpact Ltd (G) CFO Michael Weiner Sells 5,900 Shares

Genpact Ltd's CFO, Michael Weiner, sold 5,900 shares of the company's stock for approximately $200,836, bringing his direct ownership to 176,027 shares. This sale is part of a larger trend of insider selling at Genpact, with 14 insider sells and zero buys over the …

How Securities Lawsuits Over Trial Disclosures Will Impact Regeneron Pharmaceuticals’ (REGN) Pipeline-Driven Investment Story

Regeneron Pharmaceuticals is facing securities class action lawsuits concerning alleged misleading statements about its Phase III Fianlimab-Libtayo trial. These lawsuits, focusing on disclosure practices regarding trial delays and failure, could influence investor perception of Regeneron's pipeline-driven strategy, especially as the company advances new programs …

Genpact (NYSE:G) Delivers Dividend Quality with a Sustainable Payout

Genpact (NYSE:G) has been identified as a quality dividend stock due to its sustainable payout, as highlighted by ChartMill's "Best Dividend" screen. The company boasts a modest but well-supported dividend yield of 2.18%, a low payout ratio of 20.88%, and a consistent dividend growth …

General Mills, Inc. $GIS Stake Lessened by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly reduced its stake in General Mills (NYSE:GIS) by 93.1% in the second quarter, selling 388,561 shares and holding 28,615 shares valued at $996,000. Despite this reduction, other large institutional investors like State Street Corp, Charles Schwab Investment Management Inc., …

Vistagen Therapeutics: Runway To Fund Operations Into 2027 >VTGN

Vistagen Therapeutics (VTGN) announced a non-dilutive financing of up to $100 million with HealthCare Royalty Partners. This agreement extends the company's financial runway into 2027, allowing it to advance its late-stage clinical programs. The initial $50 million will support the Phase 3 PALISADE-2 trial …

5 Insightful Analyst Questions From Genesis Energy’s Q2 Earnings Call

5 Insightful Analyst Questions From Genesis Energy's Q2 Earnings Call Genesis Energy delivered a strong Q2, with revenue and profit significantly outpacing Wall Street expectations. Management attributed these results to a combination of successful asset sales, cost-saving initiatives, and opportunistic margin gains from temporary …

Don't Buy Legal & General Group Plc (LON:LGEN) For Its Next Dividend Without Doing These Checks

Wall Street Zen Upgrades Regeneron Pharmaceuticals (NASDAQ:REGN) to Strong-Buy

Wall Street Zen has upgraded Regeneron Pharmaceuticals (NASDAQ:REGN) from a "buy" to a "strong-buy" rating. This upgrade follows Regeneron's strong quarterly earnings, where it surpassed analyst expectations for both EPS and revenue. Despite positive news regarding pipeline expansion and collaborations, the company faces risks …

GenusPlus Group (ASX:GNP) Gains 86.86% in a Year as Acquisition and Grid Work Expand Its Footprint

Telecom Argentina Stet - France Telecom (NYSE:TEO) Downgraded by Wall Street Zen to Hold

Wall Street Zen downgraded Telecom Argentina (NYSE:TEO) from "Buy" to "Hold," aligning with the overall analyst consensus. The company's shares opened at $13.34, and despite mixed analyst sentiment with some increasing price targets and a director purchasing shares, the average price target is $15.43. …

NervGen Pharma (NASDAQ:NGEN) Stock Rating Lowered by Wall Street Zen

Generac Holdings Inc (GNRC) News, Articles, Events & Latest Updates

This article provides recent news and updates concerning Generac Holdings Inc. (GNRC), including analyst price targets suggesting a significant upside and discussions on the company's performance relative to its sector. It highlights Generac's strong data center backlog and the impact of recent earnings reports …

Lasa Supergenerics reports standalone net loss of Rs 3.58 crore in the June 2026 quarter